The concentration of metformin required to enhance DCA anti-cancer activity towards VM-M3 cells did not promote AMPK activation or modulation of the downstream target ACC1, suggesting AMPK activity is not necessary for the observed cytotoxicity (Fig 4D, S3 Fig). The gene discussed is ACACA; the disease is cancer.